StockData

Universe Pharmaceuticals INC (UPC) stock

UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.51−0.02 (-1.31%)

Close on Nov 13, 2026Market cap $850.64KP/E –Yield –

Earnings

Universe Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Universe Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Universe Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Universe Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Universe Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K exhibit EX-99.1
    6-K
  2. FORM OF PROXY CARD TO BE MAILED TO SHAREHOLDERS OF THE COMPANY FOR USE IN CONNECTION WITH THE 2026 ANNUAL GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY
    6-K
  3. UNIVERSE PHARMACEUTICALS INC. AND SUBSIDIARIES
    6-K
  4. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
    6-K
  5. PRESS RELEASE -- UNIVERSE PHARMACEUTICALS INC ANNOUNCES STRATEGIC ACQUISITION TO EXPAND PHARMACEUTICAL PATENT PORTFOLIO
    6-K
  6. PRESS RELEASE - UNIVERSE PHARMACEUTICALS INC ANNOUNCES EFFECTIVE DATE OF DUAL-CLASS SHARE STRUCTURE
    6-K
  7. 6-K exhibit EX-99.1
    6-K
  8. FORM OF PROXY CARD TO BE MAILED TO SHAREHOLDERS OF THE COMPANY FOR USE IN CONNECTION WITH THE 2025 ANNUAL GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY
    6-K
  9. PRESS RELEASE - UNIVERSE PHARMACEUTICALS INC ANNOUNCES SHARE CONSOLIDATION
    6-K
  10. PRESS RELEASE - UNIVERSE PHARMACEUTICALS INC RECEIVES STAFF DETERMINATION NOTICE FROM NASDAQ RELATED TO DELAYED ANNUAL REPORT
    6-K
  11. 6-K exhibit EX-99.1
    6-K
  12. FORM OF PROXY CARD TO BE MAILED TO SHAREHOLDERS OF THE COMPANY FOR USE IN CONNECTION WITH THE MARCH 2025 EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY
    6-K
  13. PRESS RELEASE - UNIVERSE PHARMACEUTICALS INC RECEIVES NASDAQ DELISTING NOTICE SUBJECT TO HEARING REQUEST
    6-K
  14. (incorporated in the Cayman Islands with limited liability)
    6-K
  15. Universe Pharmaceuticals INC (the “Company”)
    6-K

See a number that looks wrong?